Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1
Diagnosis and Management of Fungal Infections
0301 basic medicine
570
Epidemiology
Virulence Factors
[SDV]Life Sciences [q-bio]
Radboud University Medical Center
Infectious disease (medical specialty)
FOS: Health sciences
Epidemiology and Management of Fungal Infections
Cohort Studies
Betacoronavirus
03 medical and health sciences
SDG 3 - Good Health and Well-being
Observational study
Virology
616
Health Sciences
Humans
Intensive care medicine
Disease
Internal medicine
Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences
Invasive Pulmonary Aspergillosis
0303 health sciences
SARS-CoV-2
Epidemiology and Pathogenesis of Pneumocystis Pneumonia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Cohort
COVID-19
Outbreak
3. Good health
[SDV] Life Sciences [q-bio]
Coronavirus disease 2019 (COVID-19)
Infectious Diseases
Medicine
Pulmonary Aspergillosis
Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences
Cohort study
2019-20 coronavirus outbreak
DOI:
10.3201/eid2711.211174
Publication Date:
2021-10-20T03:31:58Z
AUTHORS (32)
ABSTRACT
Realizamos un estudio observacional para investigar la incidencia en la unidad de cuidados intensivos, los factores de riesgo y los resultados de la aspergilosis pulmonar asociada a la enfermedad por coronavirus (capa). Encontramos una incidencia de capa del 10%-15% entre 823 pacientes en 2 cohortes. Varios factores se asociaron independientemente con capa en 1 cohorte y las tasas de mortalidad fueron del 43%-52%.<br/>أجرينا دراسة رصدية للتحقيق في حدوث وحدة العناية المركزة وعوامل الخطر ونتائج داء الرشاشيات الرئوي المرتبط بفيروس كورونا (CAPA). وجدنا 10 ٪-15 ٪ من حالات CAPA بين 823 مريضًا في مجموعتين. ارتبطت عدة عوامل بشكل مستقل مع CAPA في مجموعة واحدة وكانت معدلات الوفيات 43 ٪-52 ٪.<br/>Nous avons réalisé une étude observationnelle pour étudier l'incidence, les facteurs de risque et les résultats de l'aspergillose pulmonaire associée à la maladie à coronavirus (CAPA) dans les unités de soins intensifs. Nous avons trouvé une incidence de 10 % à 15 % de CAPA chez 823 patients dans 2 cohortes. Plusieurs facteurs ont été indépendamment associés à la CAPA dans 1 cohorte et les taux de mortalité étaient de 43 % à 52 %.<br/>We performed an observational study to investigate intensive care unit incidence, risk factors, and outcomes of coronavirus disease-associated pulmonary aspergillosis (CAPA). We found 10%-15% CAPA incidence among 823 patients in 2 cohorts. Several factors were independently associated with CAPA in 1 cohort and mortality rates were 43%-52%.<br/>
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (15)
CITATIONS (109)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....